SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-23-042133
Filing Date
2023-04-05
Accepted
2023-04-05 16:00:35
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2311843d1_sc13da.htm SC 13D/A 52931
  Complete submission text file 0001104659-23-042133.txt   54153
Mailing Address CHEMIN DES MINES 9 GENEVA V8 CH-1202
Business Address CHEMIN DES MINES 9 GENEVA V8 CH-1202 01141228841555
Addex Therapeutics Ltd. (Subject) CIK: 0001574232 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91805 | Film No.: 23802393
SIC: 2834 Pharmaceutical Preparations

Mailing Address CHEMIN DES MINES 9 CH-1202 GENEVA V8 CH-1202
Business Address
Dyer Timothy Mark (Filed by) CIK: 0001830908 (see all company filings)

Type: SC 13D/A